Validation of the OncoDEEP® Kit comprehensive genomic panel on the MGI platform

Introduction :

This study aims to compare tumour characterization using the OncoDEEP® Kit end-to-end solution with an MGI sequencer as an alternative to Illumina technology. The validation results demonstrate that the MGI platform, by generating high-quality data, represents an excellent alternative, with all variant and fusion detections being comparable. Furthermore, the correlation of genomic signatures using data from MGI sequencing shows a high concordance with Illumina. Explore this poster to discover why MGI technology might be considered a cost-effective alternative to Illumina technology.

You may also be interested in these resources

News / Events

Festival Of Genomics January 2025

We help you navigate a complex genomics ecosytem OncoDNA understands the complexities of the personalized medicine ecosystem and leverages over 10 years of expertise in genomic profiling to guide laboratories and oncologists in their use...

Video

Voice Of Customer – Episode 2

In this episode, Pr. Daniela Cesselli (University of Udine) discusses the strategic needs that drove the adoption of a CGP panel and the reasons behind choosing the 𝗢𝗻𝗰𝗼𝗗𝗘𝗘𝗣® 𝗞𝗶𝘁 solution. Was it to ensure timely...

Share This